Hemodialysis & Peritoneal Dialysis Market 2018 Forecasts in New Research Report at RnRMarketResearch.com

RnRMarketResearch.com adds “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018” to its store. As of 2013, North America (comprising the U.S. and Canada) holds the largest share of the global dialysis market.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
The Dialysis market is estimated at $61.60 billion in 2013 and is poised to grow at a CAGR of 6.2% from 2013 to 2018, to reach $83.21 billion by 2018.

Dallas, Texas (PRWEB) November 17, 2013

The global dialysis market is broadly categorized into two segments, namely, hemodialysis (products & services) and peritoneal dialysis (products & services). The hemodialysis segment accounts for the larger share of the global dialysis market, while the peritoneal dialysis segment is expected to grow at a higher CAGR in the forecast period. The hemodialysis (HD) products and services market includes machines, consumables, and services. The peritoneal dialysis (PD) products and services market includes concentrates/dialysates, cyclers, catheters, transfer sets, accessories, and PD services.

Moreover, the global dialysis market has also been classified on the basis of end users into in-center dialysis and home dialysis. The hemodialysis market is further segmented into center use HD and home HD. The peritoneal dialysis market is segmented into continuous cycling peritoneal dialysis (CCPD), continuous ambulatory peritoneal dialysis (CAPD), intermittent PD, and PD Plus therapy. The in-center dialysis end users market includes hospitals and independent dialysis centers; whereas, the home dialysis end users market includes peritoneal dialysis end users and home hemodialysis end users. Based on geography, the market is divided into North America, Asia-Pacific, Europe, and Rest of the World (RoW).

Complete report available @ http://www.rnrmarketresearch.com/dialysis-market-hemodialysis-machine-dialyzer-bloodlines-concentrates-services-peritoneal-dialysis-cycler-catheter-dialysate-ccpd-capd-ipd-end-users-hospital-independent-dialys-market-report.html .

A number of factors such as the growing number of end stage renal disease patients and increasing prevalence of diabetes and hypertension are driving the growth of the dialysis market. In addition, factors such as low preference of patients for kidney transplantation, technological advancements, increase in private investment and venture funding to support the development of new products, and substantial government healthcare expenditure on the treatment of end-stage renal disease are further stimulating the growth of the dialysis products and services market. However, factors such as low awareness about kidney diseases and their treatment modalities (primarily in developing countries), reduction in Medicare reimbursements to dialysis centers, product recalls, and reuse of hemodialysis consumables (such as dialyzers and bloodlines) are restraining the growth of the dialysis market.

In 2013, North America holds the largest share in the global dialysis market, followed by Asia-Pacific, Europe, and RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China, South Korea, India, and Rest of Asia-Pacific) is estimated to grow at the highest CAGR in the forecast period. Factors such as the increasing number of independent dialysis centers, government initiatives to develop dialysis facilities, and increasing awareness about new dialysis treatment modalities are driving the growth of the dialysis market in the Asia-Pacific region.

The major players in the dialysis market include Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Diaverum Deutschland GmbH (Germany), Medical Components, Inc. (U.S.), Nikkiso Co. Ltd. (Japan), and NxStage Medical, Inc. (U.S.).

Major Point of table of content:

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Asahi Kasei Medical Co., Ltd.
11.2 B. Braun Melsungen Ag
11.3 Baxter International, Inc.
11.4 Bellco S.R.L.
11.5 Covidien, Plc
11.6 Davita Healthcare Partners, Inc.
11.7 Diaverum Deutschland Gmbh
11.8 Fresenius Medical Care Ag & Co. Kgaa
11.9 Gambro Ab
11.10 Kawasumi Laboratories, Inc.
11.11 Medical Components, Inc.
11.12 Medionics International, Inc.
11.13 Nikkiso Co. Ltd.
11.14 Nipro Corporation
11.15 Nxstage Medical, Inc

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=129563 .

Browse more reports on Medical Devices Market @ http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's Google Plus